Administration of a Nondepleting Anti-CD4 Monoclonal Antibody (W3/25) Prevents Adjuvant Arthritis, Even upon Rechallenge: Parallel Administration of a Depleting Anti-CD8 Monoclonal Antibody (OX8) Does Not Modify the Effect of W3/25 | Publicación